Mutational Analysis of SH2B3 in Korean Patients With BCR-ABL1 Negative Myeloproliferative Neoplasm

Ítems similars

• Risk-Reducing Genetic Variant of Wilms Tumor 1 Gene rs16754 in Korean Patients With BCR-ABL1-Negative Myeloproliferative Neoplasm
  per: Kim, Namhee, et al.
  Publicat: (2015)
• Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms
  per: Barcelos, Michelle Maccarini, et al.
  Publicat: (2011)
• Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm
  per: Hassan, Abdulaziz, et al.
  Publicat: (2015)
• GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms
  per: Yang, Naery, et al.
  Publicat: (2018)
• The natural history and treatment outcome of blast phase BCR-ABL(−) myeloproliferative neoplasms
  per: Tam, Constantine S., et al.
  Publicat: (2008)